Regenerative potential of Houttuynia cordata Chameleon in an acute pneumonia model
Open Access
- 1 January 2025
- other
- Published by International Society of Communication and Development Between Universities (ISCDBU) in Journal of Medicinal and Chemical Sciences
- Vol. 8 (1) , 31-42
Abstract
This study investigates the potential of natural compounds, particularly from medicinal plants, in the treatment of inflammatory processes. Compared to synthetic drugs, natural agents often provide mild immunomodulatory effects, exhibit low toxicity, and support the immune, nervous, and endocrine systems through complex biologically active substances. These properties make plant-derived compounds an essential focus for current research, especially in the context of inflammatory diseases and immune modulation. Among the diverse flora of Kazakhstan, Houttuynia cordata ‘Chameleon’ shows promise as an anti-inflammatory, antiviral, antioxidant, and antitumor agent. Previous studies, including research by Hong Kong University of Chinese Medicine, demonstrate the immunomodulatory properties of Houttuynia cordata, which may aid in preventing viral infections, such as those caused by SARS-CoV-2. The plant's bioactive compounds appear to support cell-mediated immunity, underscoring the potential of natural compounds in pharmacology and related fields such as cell biology, immunology, and pathophysiology. This study aims to further examine these mechanisms, highlighting the medicinal potential of Kazakhstan’s unique flora.Keywords
This publication has 14 references indexed in Scilit:
- Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology featuresMolecular and Cellular Biochemistry, 2022
- An overview of some potential immunotherapeutic options against COVID-19International Immunopharmacology, 2021
- Acute and subacute toxicity evaluation of Houttuynia cordata ethanol extract and plasma metabolic profiling analysis in both male and female ratsJournal of Applied Toxicology, 2021
- Fight against novel coronavirus: A perspective of medicinal chemistsEuropean Journal of Medicinal Chemistry, 2020
- A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virusVirology, 2019
- Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysisThe Lancet Global Health, 2019
- The Enduring Challenge of Determining Pneumonia Etiology in Children: Considerations for Future Research PrioritiesClinical Infectious Diseases, 2017
- Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumoniaPneumonia, 2016
- Acute Respiratory Distress Syndrome: Role of Oleic Acid‐Triggered Lung Injury and InflammationMediators of Inflammation, 2015
- mCLCA3 Modulates IL-17 and CXCL-1 Induction and Leukocyte Recruitment in Murine Staphylococcus aureus PneumoniaPLOS ONE, 2014